CD274 and neoplasm: Treatment of tumor-associated macrophages with anti-PD-L1 antibodies confers a pro-inflammatory phenotype, with increased expression of inducible nitric oxide synthase (iNOS), MHC II, TNF-α, and CD40 (36, 37).